CHINA PHARMA<01093> - Results Announcement (Summary)
China Pharmaceutical Group Limited announced on 12/08/2003:
(stock code: 01093 )
Year end date: 31/12/2003
Currency: HKD
Auditors' Report: N/A
Review of Interim Report by: Both Audit Committee and Auditors
(Unaudited )
(Unaudited ) Last
Current Corresponding
Period Period
from 01/01/2003 from 01/01/2002
to 30/06/2003 to 30/06/2002
Note ($ ) ($ )
Turnover : 1,360,282,000 705,193,000
Profit/(Loss) from Operations : 437,521,000 130,619,000
Finance cost : (14,575,000) (12,725,000)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : 3,050,000 4,081,000
Profit/(Loss) after Tax & MI : 359,361,000 101,161,000
% Change over Last Period : +255 %
EPS/(LPS)-Basic (in dollars) : 0.2392 0.0812
-Diluted (in dollars) : 0.2343 0.08
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 359,361,000 101,161,000
Interim Dividend : 7.00 cents NIL
per Share
(Specify if with other : N/A N/A
options)
B/C Dates for
Interim Dividend : 01/09/2003 to 05/09/2003bdi.
Payable Date : 26/09/2003
B/C Dates for (-)
General Meeting : N/A
Other Distribution for : N/A
Current Period
B/C Dates for Other
Distribution : N/A
Remarks:
1. Profit from operations
For the six months ended June 30,
2003 2002
HK$ HK$
Profit from operations has been arrived
at after charging (crediting):
Allowance for bad and doubtful debts - 5,450,000
Amortisation of intangible assets 6,873,000 7,566,000
Depreciation of property, plant and equipment
63,111,000 47,359,000
Bank interest income (774,000) (480,000)
=================================
2. Earnings per share
The calculation of the basic and diluted earnings per share is based on
the following data:
For the six months ended June 30,
2003 2002
Profit attributable to shareholders HK$359,361,000 HK$101,161,000
==================================
Weighted average number of ordinary
shares for the purposes of basic
earnings per share 1,502,212,661 1,245,580,163
Effect of dilutive potential ordinary
shares in respect of share options 31,350,946 19,661,140
---------------------------------
Weighted average number of ordinary
shares for the purposes of diluted
earnings per share 1,533,563,607 1,265,241,303
================================
|
